Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Staerk · SciRah

Researcher profile · Semantic Scholar

L. Staerk

Share profile

L. Staerk — researcher profile on SciRah

h-index: 25
Works: 71
Citations: 3,252

Most-cited papers

Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes
L. Staerk, J. Sherer, D. Ko, E. Benjamin +1 more
2017Circulation Research959 citations Open access
Semantic Scholar
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
L. Staerk, Bi-Qi Wang, S. Preis, M. Larson +9 more
2018British medical journal332 citations Open access
Semantic Scholar
Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation
Lu-Chen Weng, S. Preis, Olivia L. Hulme, M. Larson +10 more
2017Circulation220 citations Open access
Semantic Scholar
Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark
K. Gadsbøll, L. Staerk, E. Fosbøl, C. Sindet-Pedersen +4 more
2017European Heart Journal186 citations
Semantic Scholar
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
L. Staerk, G. Lip, J. Olesen, E. Fosbøl +7 more
2015British medical journal154 citations Open access
Semantic Scholar
Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
M. Lamberts, L. Staerk, J. Olesen, E. Fosbøl +5 more
2017Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease144 citations Open access
Semantic Scholar
Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study
Nicklas Vinter, P. Cordsen, S. Johnsen, L. Staerk +3 more
2024British medical journal108 citations Open access
Semantic Scholar
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
L. Staerk, E. Fosbøl, K. Gadsbøll, C. Sindet-Pedersen +6 more
2016Scientific Reports96 citations Open access
Semantic Scholar
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
L. Staerk, T. Gerds, G. Lip, B. Ozenne +6 more
2018Journal of Internal Medicine95 citations Open access
Semantic Scholar
Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study
L. Staerk, E. Fosbøl, G. Lip, M. Lamberts +6 more
2016European Heart Journal93 citations Open access
Semantic Scholar
Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation: An Observational Cohort Study
A. Bonde, G. Lip, A. Kamper, E. Fosbøl +5 more
2016Stroke50 citations Open access
Semantic Scholar
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study
Michelle T. Long, Xiao-Yan Yin, M. Larson, P. Ellinor +9 more
2017Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease48 citations Open access
Semantic Scholar
Protein Biomarkers and Risk of Atrial Fibrillation: The Framingham Heart Study
L. Staerk, S. Preis, Hong-Huang Lin, S. Lubitz +4 more
2020Circulation: Arrhythmia and Electrophysiology47 citations Open access
Semantic Scholar
Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.
C. Binding, Jonas Bjerring Olesen, B. Abrahamsen, L. Staerk +2 more
2019Journal of the American College of Cardiology45 citations Open access
Semantic Scholar
Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
A. Bonde, P. Blanche, L. Staerk, T. Gerds +6 more
2019European Heart Journal45 citations
Semantic Scholar
Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
C. Sindet-Pedersen, M. Lamberts, L. Staerk, Anders Nissen Bonde +6 more
2018Journal of the American College of Cardiology45 citations Open access
Semantic Scholar
Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis.
Marco Proietti, Giulio Francesco Romiti, I. Romanazzi, A. Farcomeni +3 more
2018International Journal of Cardiology39 citations Open access
Semantic Scholar
Thiazolidinediones are associated with a decreased risk of atrial fibrillation compared with other antidiabetic treatment: a nationwide cohort study
J. Pallisgaard, T. B. Lindhardt, L. Staerk, J. Olesen +3 more
2016European Heart Journal - Cardiovascular Pharmacotherapy39 citations Open access
Semantic Scholar
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
J. Pallisgaard, T. B. Lindhardt, M. L. Hansen, A. Schjerning +4 more
2015PLoS ONE37 citations Open access
Semantic Scholar
Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.
A. Schjerning Olsen, P. McGettigan, T. Gerds, E. Fosbøl +9 more
2019European Heart Journal - Cardiovascular Pharmacotherapy34 citations Open access
Semantic Scholar
Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study
L. Staerk, E. Fosbøl, M. Lamberts, A. Bonde +9 more
2018European Heart Journal34 citations
Semantic Scholar
Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism
C. Sindet-Pedersen, J. Pallisgaard, L. Staerk, T. Gerds +4 more
2017Thrombosis and Haemostasis31 citations
Semantic Scholar
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study.
L. Staerk, G. Gislason, G. Lip, E. Fosbøl +5 more
2015Europace29 citations Open access
Semantic Scholar
Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control.
A. Bonde, L. Staerk, C. Lee, N. Vinding +5 more
2018Journal of the American College of Cardiology25 citations Open access
Semantic Scholar
Initiation of anticoagulation in atrial fibrillation: which factors are associated with choice of anticoagulant?
A. Gundlund, L. Staerk, E. L. Fosbøl, K. Gadsbøll +4 more
2017Journal of Internal Medicine25 citations Open access
Semantic Scholar
Aalborg Universitet Temporal trends in initiation of VKA , rivaroxaban , apixaban and dabigatran for the treatment of venous thromboembolism
C. Sindet-Pedersen, J. Pallisgaard, L. Staerk, Berger +5 more
201725 citations
Semantic Scholar
Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation
E. Fosbøl, N. Vinding, M. Lamberts, L. Staerk +5 more
2018Europace24 citations Open access
Semantic Scholar
Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study
C. Sindet-Pedersen, L. Staerk, J. Pallisgaard, T. Gerds +4 more
2018European Heart Journal - Cardiovascular Pharmacotherapy24 citations Open access
Semantic Scholar
Renal Function, Time in Therapeutic Range and Outcomes in Warfarin-Treated Atrial Fibrillation Patients: A Retrospective Analysis of Nationwide Registries
A. Bonde, G. Lip, A. Kamper, L. Staerk +3 more
2017Thrombosis and Haemostasis24 citations
Semantic Scholar
All-cause mortality, stroke, and bleeding in patients with atrial fibrillation and valvular heart disease.
J. Strange, C. Sindet-Pedersen, L. Staerk, E. Grove +4 more
2020European Heart Journal - Cardiovascular Pharmacotherapy23 citations Open access
Semantic Scholar
Association Between Leukocyte Telomere Length and the Risk of Incident Atrial Fibrillation: The Framingham Heart Study
L. Staerk, Bi-Qi Wang, K. Lunetta, Robert H. Helm +8 more
2017Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease23 citations Open access
Semantic Scholar
Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation
A. Bonde, T. Martinussen, C. Lee, G. Lip +7 more
2020Circulation. Cardiovascular Quality and Outcomes22 citations Open access
Semantic Scholar
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation
C. Sindet-Pedersen, L. Staerk, M. Lamberts, T. Gerds +7 more
2017Heart20 citations
Semantic Scholar
Novel risk modeling approach of atrial fibrillation with restricted mean survival times: application in the Framingham Heart Study community-based cohort
L. Staerk, S. Preis, Hong-Huang Lin, J. Casas +7 more
2020Circulation. Cardiovascular Quality and Outcomes18 citations Open access
Semantic Scholar
Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients.
A. Bonde, G. Lip, A. Kamper, L. Staerk +3 more
2017Journal of the American College of Cardiology17 citations Open access
Semantic Scholar
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
Emma Kirstine Laugesen, L. Staerk, N. Carlson, A. Kamper +4 more
2019Thrombosis Journal16 citations Open access
Semantic Scholar
Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study
A. Gundlund, J. Olesen, L. Staerk, C. Lee +6 more
2016Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease12 citations Open access
Semantic Scholar
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
C. Sindet-Pedersen, J. Pallisgaard, L. Staerk, J. Berger +4 more
2017Scientific Reports11 citations Open access
Semantic Scholar
2049Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
L. Staerk, T. Gerds, G. Lip, B. Ozenne +6 more
20177 citations Open access
Semantic Scholar
Periprocedural myocardial infarktion: does it really matter?
L. Staerk, Jacob Bjerring Olesen, C. Torp-Pedersen, M. L. Hansen +2 more
20147 citations Open access
Semantic Scholar
Efficacy and safety of oral anticoagulants according to kidney function among patients with atrial fibrillation.
C. Binding, P. Blanche, G. Lip, A. Kamper +6 more
2024European Heart Journal - Cardiovascular Pharmacotherapy5 citations Open access
Semantic Scholar
P1256Resumption of anticoagulant treatment in patients with atrial fibrillation following gastrointestinal bleeding: a nationwide cohort study
D. Rajan, A. Bonde, J. Olesen, M. Lamberts +4 more
2019European Heart Journal5 citations
Semantic Scholar
Switching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation: Differences According to Dose.
N. Vinding, L. Staerk, G. Gislason, C. Torp-Pedersen +6 more
2019European Heart Journal - Cardiovascular Pharmacotherapy4 citations
Semantic Scholar
Predicted risk of stroke and bleeding and use of oral anticoagulants in atrial fibrillation: Danish nationwide temporal trends 2011-2016.
A. Dukanovic, L. Staerk, E. Fosbøl, K. Gadsbøll +2 more
2017Thrombosis Research4 citations Open access
Semantic Scholar
Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation
A. Bonde, G. Lip, A. Kamper, E. Fosbøl +5 more
20163 citations
Semantic Scholar
Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation
J. Pallisgaard, G. Gislason, C. Torp-Pedersen, C. Lee +4 more
2016PLoS ONE2 citations Open access
Semantic Scholar
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation
L. Staerk, B. Jonas, L. Jannik
20161 citations
Semantic Scholar
Highlights From the Circulation Family of Journals.
L. Staerk, Sarah R. Preis, Hong-Huang Lin, S. Lubitz +3 more
2020Circulation0 citations
Semantic Scholar
P4757Vitamin k antagonists are associated with higher risk of osteoporotic fractures compared to non-vitamin k antagonist oral anticoagulants among atrial fibrillation patients: a nationwide cohort study
C. Binding, Jacob Bjerring Olesen, B. Abrahamsen, L. Staerk +2 more
2019European Heart Journal0 citations
Semantic Scholar
P4779High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban
A. Bonde, T. Martinussen, C. Lee, J. Bhattacharya +6 more
2019European Heart Journal0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Gislason×35
Invite
G. Gislason — researcher profile on SciRah
J. Olesen×34
Invite
J. Olesen — researcher profile on SciRah
C. Torp-Pedersen×26
Invite
C. Torp-Pedersen — researcher profile on SciRah
A. Bonde×20
Invite
A. Bonde — researcher profile on SciRah

×18

Invite

E. Fosbøl — researcher profile on SciRah

M. Lamberts×14

Invite

M. Lamberts — researcher profile on SciRah

C. Sindet-Pedersen×13

Invite

C. Sindet-Pedersen — researcher profile on SciRah

Invite

G. Lip — researcher profile on SciRah

J. Pallisgaard×11

Invite

J. Pallisgaard — researcher profile on SciRah

Invite

T. Gerds — researcher profile on SciRah

M. L. Hansen×8

Invite

M. L. Hansen — researcher profile on SciRah

Invite

E. Benjamin — researcher profile on SciRah